1. Achenbach S, Szardien S, Zeymer U, Gielen S, Hamm CW: Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Therapie des akuten Koronarsyndroms ohne persistierende ST-Streckenhebung. Der Kardiologe 6: 283–301; 2012
2. Acher R, Chauvet J, Rouille Y: Dynamic processing of Neuropeptides-Sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport. J Mol Neurosci 18: 223-228; 2002 3. Adams JE, Bodor GS, Davila-Roman VG, Delinez JA, Apple FS, Ladenson JM,
Jaffe AS: Cardiac troponin I - A marker with high specificity for cardiac injury.
Circulation 88: 101-106; 1993
4. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox KAA, Hasdai D, Ohman EM, Wallentin L, Wijns W: Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28: 1598-1660; 2007
5. Bruins Slot MH, Reitsma JB, Rutten FH, Hoes AW, van der Heijden GJ:
Heart-type fatty acid-binding protein in the early diagnosis of myocardial infarction: a systematic review and meta-analysis. Heart 96(24):1957-1963;
2010
6. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, Ornato JP, Barron HV, Kiefe CI: Prevalence, Clinical Characteristics and Mortality Among Patients with Myocardial Infarction Presenting Without Chest Pain. JAMA 283: 3223–3229; 2000
7. Darius H und Meyer J: Thrombolytische Therapie bei akutem Myokardinfarkt.
In: Unger F, Mörl H, Dieterich HA (Hrsg.): Interventionen am Herzen. 1.
Auflage, 60, Springer, Heidelberg, 2012
8. Dean KJ: Biochemistry and molecular biology of troponins I and T. In: Wu AHB, (Ed.) Cardiac markers. Pathology and laboratory medicine. 193–204;
Humana, Totowa NJ 1998
9. Enhörning S, Wang TJ, Nilsson PM, Almgren P, Hedblad B, Berglund G, Struck J, Morgenthaler NG, Bergmann A, Lindholm E, Groop L, Lyssenko V, Orho-Melander M, Newton-Cheh C, Melander O: Plasma Copeptin and the Risk of Diabetes Mellitus. Circulation 121 (19): 2102-2108; 2010
10. Ekelund U, Forberg JL: New methods for improved evaluation of patients with suspected acute coronary syndrome in the emergency department.
Emerg Med J 24: 811-814; 2007
11. Fox N, Growdon JH: Biomarkers and Surrogates. NeuroRx 1: 181; 2004
Literatur
12. French JK, White HD: Implications of the new definition of myocardial infarction. Heart 90: 99 –106; 2004
13. Fung C, Marchis GM, Katan M, Seiler M, Arnold M, Gralla J, Raabe A, Beck J: Copeptin as a Marker for Severity and Prognosis of Aneurysmal
Subarachnoid Hemorrhage. PLoS One 8 (1): e53191; 2013
14. Giannitsis E, Kurowski V, Schwabe K, Stierle U: Koronare Herzkrankheit. In:
Renz-Polster H, Krautzig S (Hrsg.): Basislehrbuch Innere Medizin. 4.
Auflage, 67-68, Elsevier, München 2008
15. Gößwald A, Schienkiewitz A, Nowossadeck E, Busch MA : Prävalenz von Herzinfarkt und koronarer Herzkrankheit bei Erwachsenen im Alter von 40 bis 79 Jahren in Deutschland - Ergebnisse der Studie zur Gesundheit
Erwachsener in Deutschland (DEGS1) Bundesgesundheitsblatt 56: 650–655;
2013
16. Hacker N, Obermayer-Pietsch B: Ein Hormon stellt sich vor: Copeptin (CT-pro-AVP) ein neuer Biomarker. Journal für klinische Endokrinologie und Stoffwechsel 6: 41-42; 2013
17. Haltern G, Peiniger S, Bufe A, Reiss G, Gülker H, Scheffold T: Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am J Cardiol 105 (1):1-9; 2010 18. Jaffe AS, Ravkilde J, Robert Roberts R, Naslund U, Apple FS, Galvani M,
Katus H: It´s time for a change to a troponin standard. Circulation 102:1216-1220; 2000
19. Katan M, Morgenthaler NG, Dixit KC, Rutishauser J, Brabant GE, Müller B, Christ-Crain M: Anterior and posterior pituitary function testing with
simultaneous insulin tolerance test and a novel copeptin assay. J Clin Endocrinol Metab 92: 2640-2643; 2007
20. Katan M, Nigro N, Fluri F, Schuetz P, Morgenthaler NG, Jax F, Meckel S, Gass A, Bingisser R, Steck A, Kappos L, Engelter S, Muller B, Christ-Crain M: Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology 76: 563-566; 2011
21. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, Roth A, Bickel C, Baldus S, Sinning CR, Wild PS, Lubos E, Peetz D, Kunde J, Hartmann O, Bergmann A, Post F, Lackner KJ, Genth-Zotz S, Nicaud V, Tiret L, Munzel TF, Blankenberg S: Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 55: 2096-2106; 2010
22. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL: C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction:
Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 115: 2103-2110; 2007
Literatur
23. Ladue JS, Wroblewski F, Karmen A: Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction.
Science 120: 497-499; 1954
24. Liebetrau C, Nef H, Szardien S, Dörr O, Willmer M, Voss S, Troidl C, Hoffmann J, Rixe J, Rolf A, Hamm C, Möllmann H : Release Kinetics of Copeptin in Patients undergoing Transcoronary Ablation of Septal Hypertrophie. Clin Chem 59: 566-569; 2013
25. Lott JA, Stang, JM: Differential diagnosis of patients with abnormal serum creatine kinase isoenzymes. Clin Lab Med 9: 627-642; 1989
26. Masiá M, Papassotiriou J, Morgenthaler NG, Hernandez I, Shum C, Gutierrez F: Midregional pro-A-type natriuretic peptide and carboxy-terminal
provasopressin may predict prognosis in community acquired pneumonia.
Clin Chem 53: 2193-2201; 2007
27. Möckel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C, Müller C, Muller R, Peitsmeyer P, von Recum P, Tajsic M,
Vollert JO, Giannitsis E: Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 36: 369-376; 2015
28. Morgenthaler NG: Die Bedeutung von Copeptin als kardiovaskulärer und renaler Biomarker. Herz 35: (Suppl. III) 2010
29. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M:
Copeptin, a stable peptide of the arginin vasopressin precurser, is elevated in hemorrhagic and septic shock. Shock 28: 219-226; 2007
30. Müller B, Morgenthaler N, Stolz D, Schütz P, Müller C, Bingisser R,
Bergmann A, Tamm M, Christ-Crain M: Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 37: 145-152;
2007
31. Müller M, Giannitsis E., Katus H.A. Essenzielle kardiale Biomarker bei Myokardinfarkt und Herzinsuffizienz. Herz 39: 727–742; 2014
32. Müller-Bardoff M, Hallermayer K, Schroder A, Ebert C, Borgya A, Gerhardt W, Remppis A, Zehelein J, Katus HA: Improved troponin T ELISA specific for cardiac troponin T isoform: Assay development and analytical and clinical validation. Clin Chem 43: 458–466; 1997
33. Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler N, Bergmann A, Moertl D, Berger R, Pacher R: Comparison of copeptin, B-type natriuretic peptide, and amino-terminal Pro-B-type natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 52: 266-272; 2008
Literatur
34. Neumann FJ, Cremer J, Falk V, Reifart N, Silber S, Thielmann M:
Kommentar zu den gemeinsamen „Guidelines on myocardial
revascularization“ der European Society of Cardiology (ESC) und der
European Association for Cardio-Thoracic Surgery (EACTS). Der Kardiologe 6: 94–104; 2012
35. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE Jr., Califf RM, Topol EJ: Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 335: 1333-1341; 1996
36. Panteghini, M: IFCC Committee on Standardization of Markers of Cardiac Damage: premises and project presentation. International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 36: 887-893; 1998
37. Parmacek MS, Solaro RJ: Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis 47:159–176; 2004
38. Ponte B, Pruijm M, Ackermann D, Vuistiner P, Guessous I, Ehret G, Alwan H, Youhanna S, Paccaud F, Mohaupt M, Péchère-Bertschi A, Vogt B, Burnier M, Martin P-Y, Devuyst O, Bochud M: Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study. J Am Soc Nephrol 26:1415–1425; 2015
39. Pope JH, Aufderheide P, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, Griffith JL, Selker HP: Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 342: 1163-1170; 2000
40. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays.
N Engl J Med 361(9):858-867; 2009
41. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, Bergmann A, Potocki M, Noveanu M, Breidthardt T, Christ A, Boldanova T, Merki R, Schaub N, Bingisser R, Christ M, Mueller C: Incremental value of Copeptin for Rapid rule out of acute myocardial Infarction. J Am Coll Cardiol 54: 60-68; 2009
42. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, Bassetti S, Steuer S, Winkler K, Peter F, Meissner J, Haaf P, Potocki M, Drexler B, Osswald S, Mueller C: Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 124:136-145; 2011
Literatur
43. Reichlin T, Twerenbold R, Gimenez MR, Jaeger C, Tanglay Y, Osswald S, Mueller, C: Incremental value of copeptin to high-sensitivity cardiac troponin T alone in the early diagnosis of acute myocardial infarction. Eur Heart J 35:
885; 2014
44. Rutishauser, J: Copeptin-diagnostischer Parameter, Biomarker, beides?
Therapeutische Umschau 66: 731-734; 2009
45. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N:
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105(15): 1760-1763; 2002
46. Searle J, Danne O, Müller C, Möckel M: Kardiale Biomarker beim kardialen Notfall-Luxus oder Notwendigkeit? MedWelt 61: 263-272; 2010
47. Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ.
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia.
Crit Care 12: R11; 2008
48. Smith AF, Radford D, Wong CP, Oliver MF: Creatine-Kinase MB isoenzyme studies in diagnosis of myocardial infarction. Brit Heart J 38: 225-232; 1976 49. Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, Müller C, Struck J, Müller B, Tamm M: Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
Chest 131: 1058 – 67; 2007
50. Sun H, Sun T, Ma B, Yang BW, Zhang Y, Huang DH, Shi JP: Prediction of all-cause mortality with copeptin in cardio-cerebrovascular patients: A meta-analysis of prospective studies. Peptides 69: 9-18; 2015
51. Tenderenda-Banasiuk E, Wasilewska A, Filonowicz R, Jakubowska U, Waszkiewicz-Stojda M: Serum copeptin levels in adolescents with primary hypertension. Pediatr Nephrol 29: 423-429; 2014
52. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction: Third universal definition of myocardial infarction. Eur Heart J 33:2551–2567; 2012
53. Vafaie M und Katus HA: Myokardinfarkt – Neue universelle Definition und ihre leitliniengerechte Umsetzung. Herz 38: 821-827; 2013
Literatur
54. Vaidya HC: Myoglobin-An early biochemical marker for the diagnosis of acute myocardial-infarction. J Clin Immunoassay 17: 35-39; 1994
55. Van Gastel MDA, Meijer E, Scheven LE, Struck J, Bakker SJL, Gansevoort RT: Modifiable Factors Associated With Copeptin Concentration: A General Population Cohort. Am J Kidney Dis 65: 719-727; 2015
56. Vasile VC, Jaffe: The biological basis of troponin in heart disease: possible uses for troponin fragmentology. Heart Metab 43 :5– 8; 2009
57. Wroblewski F, Ross C, Gregory K: Isoenzymes and myocardial infarction. N Engl J Med 263: 531-536; 1960
58. Wu AHB, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor G: Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 44: (Part 1) 1198-1208; 1998
59. Wu AHB, Jaffe AS: The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 155: 208-214; 2008
60. Yu WH, Wang WH, Dong XQ, Du Q, Yang DB, Shen YF, Wang H, Zhang ZY, Zhu Q, Che, ZH, Liu QJ, Jiang L, Du YF: Prognostic significance of plasma copeptin detection compared with multiple biomarkers in intracerebral hemorrhage. Clin Chim Acta 433: 174-178; 2014
61. Zeymer U, Kastrati A, Rassaf T, Scholz KH, Thiele H, Nienaber CA:
Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Therapie des akuten Herzinfarkts bei Patienten mit
ST-Streckenhebung (STEMI). Der Kardiologe 7: 410-422; 2013 62. [Keine Autoren angegeben]
https://www.destatis.de/DE/ZahlenFakten/GesellschaftStaat/Gesundheit/Tod esursachen/Tabellen/SterbefaelleInsgesamt.html (Letzter Zugriff:
27.02.2015)
63. [Keine Autoren angegeben]
Gesundheitsberichterstattung des Bundes Heft 33 Robert Koch Institut (Hrsg): Koronare Herzkrankheit und akuter Myokardinfarkt; 2006
Literatur
64. [Keine Autoren angegeben]
Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.
Circulation 59: 607-609; 1979
65. [Keine Autoren angegeben]
Weltgesundheitsorganisation
http://www.who.int/mediacentre/factsheets/fs310/en/ (Letzter Zugriff 25.02.2015)
66. [Keine Autoren angegeben]
http://www.outcomes-umassmed.org/grace/acs_risk/acs_risk_content.html (Letzter Zugriff 25.02.2015)
67. [Keine Autoren angegeben]
https://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_
start_neu/&p_aid=3&p_aid=10635704&nummer=516&p_sprache=D&p_indsp
=4065&p_aid=84903803 (Letzter Zugriff: 11.09.2015) 68. [Keine Autoren angegeben]
https://www.mdcalc.com/timi-risk-score-ua-nstemi (Letzter Zugriff 25.06.2017)
Anhang